Trademark: INFINANT HEALTH 2335515
Word
INFINANT HEALTH
ID
2335515
Trademark Type
WORD
Status
Accepted: Opposition period expired
Application Date
17 February 2023
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 5:
Pharmaceuticals and dietary supplements made of bacteria and/or their metabolic products for the gut microbiome; pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Pharmaceutical and dietary supplements made of bacteria and/or their metabolic products for the gut microbiome for the prevention or treatment of atopic, allergic, autoimmune, autism, and/or cognitive disorders in pediatric populations; preparations for restoring the gut microbiome; microbiome and immune preparations for restoring health; nutritional and dietary supplements; medicines for pregnant women and nursing mothers and their infants; foods for babies; bacterial therapeutics; bacterial derived therapeutics for food ingredients; microbiome preparations, namely, prebiotics and fiber, and/or probiotics for uses in foods and medicines.
Pharmaceuticals and dietary supplements made of bacteria and/or their metabolic products for the gut microbiome; pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Pharmaceutical and dietary supplements made of bacteria and/or their metabolic products for the gut microbiome for the prevention or treatment of atopic, allergic, autoimmune, autism, and/or cognitive disorders in pediatric populations; preparations for restoring the gut microbiome; microbiome and immune preparations for restoring health; nutritional and dietary supplements; medicines for pregnant women and nursing mothers and their infants; foods for babies; bacterial therapeutics; bacterial derived therapeutics for food ingredients; microbiome preparations, namely, prebiotics and fiber, and/or probiotics for uses in foods and medicines.
Class 42:
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders or diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and/or treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and nonpharmaceutical research and development; product research and development of medicines, nutritional and dietary supplements; Development of platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health related conditions; Development of platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and/or clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioural, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and/or diseases.
Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders or diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and/or treatment of autism; development of microbiome preparations for older adults, elderly; Pharmaceutical and nonpharmaceutical research and development; product research and development of medicines, nutritional and dietary supplements; Development of platforms technology for discovery and development of therapeutics for the treatment, prevention, palliation, and diagnosis of diseases; Research and development of products for the diagnosis of human disease or human health-related conditions; Research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health related conditions; Development of platforms for discovery and development of research for therapeutics products for the reduction of risk, diagnosis, prevention, palliation, or treatment of human diseases or human health-related conditions; Medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; Research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; Biomedical research services related to health and/or clinical status of pregnant women, preterm infants, term infants, toddlers and children; Research and development of diagnostics for biological, behavioural, auditory, and pictorial health indicators; Medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; Medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly; development of consumer devices for recording and monitoring health attributes to work in conjunction with or related to live bacterial therapeutics or food products; Development of tools for measuring and tracking infant health data for purposes of evaluating effectiveness of treatment of diseases and medical conditions; Development of maternal and infant wellness tests and applications; Development of Software as a Medical Device (SaMD); Development of Machine Learning as a Medical Device (MLaMD); Development of downloadable mobile applications for monitoring, managing, and treating medical conditions and/or diseases.